Skip to main content

Orbimed Advisors Llc

Source: SEC Form 13F · as of Mar 2026

Orbimed Advisors Llc holds 50 biotech & pharma companies tracked by BioSniper, totaling $1.51B in value as of Mar 2026 (SEC Form 13F).

Companies held

50

Total value held

$1.51B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Enliven Therapeutics, Inc. (ELVN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ELVNEnliven Therapeutics, Inc.7,959,538$312.0M
SIONSionna Therapeutics, Inc.3,530,702$141.5M
ARGXARGENX SE136,900$100.0M
CMPXCompass Therapeutics, Inc.15,219,994$80.5M
GPCRStructure Therapeutics Inc.1,475,403$71.1M
IRONDisc Medicine, Inc.1,067,550$68.3M
SPRYARS Pharmaceuticals, Inc.8,288,510$66.6M
ABVXAbivax SA465,700$51.9M
UPBUpstream Bio, Inc.5,693,589$51.2M
ALNYALNYLAM PHARMACEUTICALS, INC.119,000$39.4M
PRLDPrelude Therapeutics Inc10,909,256$37.3M
AXSMAxsome Therapeutics, Inc.213,921$36.2M
QUREuniQure N.V.2,136,149$34.9M
ORICOric Pharmaceuticals, Inc.2,693,929$34.1M
RLMDRELMADA THERAPEUTICS, INC.4,715,864$32.8M
FBRXForte Biosciences, Inc.1,196,955$31.0M
ESPREsperion Therapeutics, Inc.10,570,300$29.0M
RYTMRHYTHM PHARMACEUTICALS, INC.314,100$27.3M
STROSUTRO BIOPHARMA, INC.801,144$20.0M
NKTRNEKTAR THERAPEUTICS275,000$19.8M
PVLAPALVELLA THERAPEUTICS, INC.134,600$16.8M
CRBPCorbus Pharmaceuticals Holdings, Inc.1,737,287$16.3M
DFTXDefinium Therapeutics Inc.804,000$15.2M
WHWKWhitehawk Therapeutics, Inc.4,166,000$14.4M
BCAXBicara Therapeutics Inc.667,300$13.3M
BIOABioAge Labs, Inc.711,811$12.4M
COGTCogent Biosciences, Inc.322,100$12.4M
ALMSALUMIS INC.548,163$12.1M
REGNREGENERON PHARMACEUTICALS, INC.14,700$11.4M
KNSAKiniksa Pharmaceuticals International, plc180,599$8.7M
KROSKeros Therapeutics, Inc.759,155$8.4M
GILDGILEAD SCIENCES, INC.59,600$8.3M
HRTXHERON THERAPEUTICS, INC. /DE/9,816,940$7.9M
AVTXAvalo Therapeutics, Inc.475,165$7.1M
TECXTectonic Therapeutic, Inc.226,600$7.0M
ACETAdicet Bio, Inc.1,027,944$7.0M
CMPSCOMPASS Pathways plc1,150,646$6.4M
PHVSPharvaris N.V.205,400$5.8M
ALXOALX ONCOLOGY HOLDINGS INC2,866,256$5.7M
RVMDREVOLUTION MEDICINES, INC.52,000$5.1M
PTGXProtagonist Therapeutics, Inc42,100$4.4M
SVRASavara Inc635,000$3.5M
CGEMCullinan Therapeutics, Inc.243,006$3.5M
PTCTPTC THERAPEUTICS, INC.49,100$3.3M
JBIOJade Biosciences, Inc.185,011$2.6M
CCCCC4 Therapeutics, Inc.856,353$2.3M
KALVKalVista Pharmaceuticals, Inc.94,400$1.9M
IMAImageneBio, Inc.378,556$1.9M
VTGNVistagen Therapeutics, Inc.3,060,000$1.7M
ATAIAtai Beckley N.V.347,000$1.2M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.